Haemonetics
HAE
#3519
Rank
โ‚น351.86 B
Marketcap
โ‚น7,304
Share price
-3.70%
Change (1 day)
4.71%
Change (1 year)

EPS for Haemonetics (HAE)

EPS in 2025 (TTM): โ‚น297.92

According to Haemonetics's latest financial reports the company's current EPS (TTM) is โ‚น313.29. In 2024 the company made an earnings per share (EPS) of โ‚น232.94 an increase over its 2023 EPS that were of โ‚น227.42.

EPS history for Haemonetics from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น297.9227.9%
2024โ‚น232.942.43%
2023โ‚น227.4233.73%
2022โ‚น170.06332.49%
2021โ‚น39.32
2018โ‚น81.28-363.15%
2017-โ‚น30.89-207.1%
2016โ‚น28.84-132.28%
2015-โ‚น89.34-269%
2014โ‚น52.86-20%
2013โ‚น66.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,575 402.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
โ‚น700.38 123.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
โ‚น505.98 61.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerus
CERS
-โ‚น7.27-102.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น59.95-119.14%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
โ‚น699.45 123.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น948.32 202.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
โ‚น337.02 7.57%๐Ÿ‡ฎ๐Ÿ‡ช Ireland